Walter H. Colsman Appointed CEO of BrightSpec

September 15, 2019 BrightSpec announced the appointment of Walter H. Colsman as CEO. Mr. Colsman has over 30 years of business experience including over 15 years in the life sciences field.  Walter has most recently been advising startups and investors in the healthcare field and served as CFO of CereVasc LLC, a development stage medical device company.  Walter was a senior equity analyst at Columbia-Threadneedle Investments, where he followed the life science tools sector for 12 years. Prior to Columbia, Walter worked at Standard Pacific Capital and Palo Alto Investors, hedge funds in the San Francisco Bay Area. Before working in the investing field, Walter gained business experience as a founder and executive at several internet startups.  Walter also advised businesses on strategy at Bain & Company and the Lucas Group, as well as an analyst in financial planning for Pepsi-Cola International. Walter earned his bachelor’s degree (engineering) at Dartmouth and his M.B.A from Harvard Business School.

“Impressed with MRR and its potential, I invested and joined the board earlier this year,” said Mr. Colsman. “I am excited to work more closely with the team and realize that potential of MRR as a disruptive asset for the analytical chemist.”